After hiding birth control patch's risk, company points finger at FDA
For years, Johnson & Johnson obscured evidence that its popular Ortho Evra birth control patch delivered much more estrogen than standard birth control pills, potentially increasing the risk of blood clots and strokes, according to internal company documents. But because the Food and Drug Administration approved the patch, the company is arguing in court that…
Read More >
